Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Dechra Pharmaceuticals

9 Jan 2024 17:45

RNS Number : 1394Z
FTSE Russell
09 January 2024
 

 

 

Dechra Pharmaceuticals (UK): Constituent DeletionChanges in FTSE UK Index Series

09 January 2024

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE 100 Index

16 January 2024

FTSE 350 Index

16 January 2024

FTSE All-Share Index

16 January 2024

FTSE 350 Lower Yield Index

16 January 2024

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

 

Alternatively please visit our website at lseg.com/ftse-russell

 

Terms of Use | Copyright © 2024 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSFLFEELTIAIIS
Date   Source Headline
15th Nov 20232:49 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 20231:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Nov 20231:11 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 202311:55 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 202311:49 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Nov 202311:41 amRNSHolding(s) in Company
15th Nov 202310:41 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Nov 202310:39 amRNSForm 8.5 (EPT/RI)
15th Nov 202310:37 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:51 amRNSHolding(s) in Company
15th Nov 20239:21 amRNSForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
15th Nov 20239:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 20239:19 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Nov 20238:17 amRNSHolding(s) in Company
15th Nov 20238:16 amRNSHolding(s) in Company
15th Nov 20238:14 amRNSHolding(s) in Company
15th Nov 20237:34 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
14th Nov 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Nov 20233:14 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
14th Nov 20231:49 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
14th Nov 20231:26 pmPRNForm 8.3 - Dechra Pharmaceuticals PLC
14th Nov 20231:23 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
14th Nov 202311:11 amRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Nov 202311:06 amRNS2023 Notice of the Annual General Meeting
14th Nov 202310:24 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
14th Nov 202310:23 amRNSForm 8.5 (EPT/RI)
14th Nov 202310:19 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 202310:18 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
14th Nov 202310:17 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20239:10 amRNSForm 8.5 (EPT/NON-RI) Dehra Pharmaceuticals Plc
14th Nov 20238:53 amRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Nov 20238:30 amRNSHolding(s) in Company
14th Nov 20238:30 amRNSHolding(s) in Company
14th Nov 20238:30 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
13th Nov 20232:30 pmPRNForm 8.3 - Dechra Pharmaceuticals Plc
13th Nov 20232:04 pmRNSForm 8.5 (EPT/RI)- Replacement of Dechra
13th Nov 20231:52 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
13th Nov 20231:48 pmRNSForm 8.5 (EPT/RI)
13th Nov 202312:54 pmPRNForm 8.3 - Dechra Pharmaceuticals plc
13th Nov 202312:44 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
13th Nov 202312:10 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
13th Nov 202311:15 amRNSForm 8.3 - Dechra Pharmaceuticals plc
13th Nov 202310:23 amRNSForm 8.3 - Dechra Pharmaceuticals plc
13th Nov 202310:12 amRNSForm 8.5 (EPT/RI)
13th Nov 202310:09 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PL
13th Nov 20238:53 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
10th Nov 20234:36 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
10th Nov 20233:42 pmRNSHolding(s) in Company
10th Nov 20233:30 pmRNSForm 8.3 - DPH LN
10th Nov 20233:15 pmPRNForm 8.3 - Dechra Pharmaceuticals PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.